DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Abou-Alfa GK, Johnson P, Knox JJ , et al.
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
JAMA 2010;
304 (19) 2154-2160
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.